12.11.2010 • News • ChemistryViews • ChemPubSoc Europe • EuCheMS

Find Out What's New On Chemistry Views

Find Out Whats New On Chemistry Views

CHEManager Europe Online is proud to share some of the interesting stories our colleagues at ChemistryViews have been working on for you. ChemistryViews is a platform that presents top-quality information from ChemPubSoc Europe, an organization of 16 chemical societies in continental Europe, publishing world-leading journals such as "Chemistry - A European Journal." Click and enjoy!

Introducing the kjVIs!
Young professionals in process engineering - Serving the pipeline from school to industry!

Comic: Mess-ter Comic - ROP is Easy!
Comic series by Sophie Lin: In part 3 she depicts how chemistry can sometimes surprize you

Spotlight: Quality Of Society Journals
Quality of publishing of ChemPubSoc Europe, RSC, and ACS journals

Research Highlight: Toxic Color Test
A new lab-on-a-chip sensor array - little bigger than a business card - can detect toxic industrial chemicals at low cost and low concentrations

News: Urban Grime in Local Air Quality
In the presence of solar light and photosensitizer, nitrate may actively contribute to the photochemical pollution

Blog: Post-doc in Paris
What is a Post-Doc in Paris like? Tibiriçá Gonçalves Vasconcelos tells us why he chose Paris in his Blog. Part 2

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Top-Feature

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.